Right ventricular effects of intracoronary delivery of mesenchymal stem cells (MSC) in an animal model of pressure overload heart failure1

Biomedicine and Pharmacotherapy

Volumn 63, Issue 10, 2009, Pages 767-772

  Molina, Ezequiel J ^a   Palma, Jon ^a   Gupta, Dipin ^a   Gaughan, John P ^a   Houser, Steven ^a   Macha, Mahender ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Mesenchymal stem cells; Pressure overload heart failure; Ventricular remodeling

Indexed keywords

GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 6; PROTEIN BAK; PROTEIN BAX; STROMELYSIN; SYNAPTOPHYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CULTURE TECHNIQUE; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART RIGHT VENTRICLE; HEART VENTRICLE CONTRACTION; HISTOPATHOLOGY; INFLAMMATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART FAILURE; HEMODYNAMICS; HYPERTROPHY, LEFT VENTRICULAR; INFLAMMATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

EID: 71749112840     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.09.004     Document Type: Article

References (16)

1. Kanki-Horimoto S., Horimoto H., Mieno S., Kishida K., Watanabe F., Furuya E., et al. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 114 (2006) I181-I185
2. Wairiuko G.M., Crisostomo P.R., Wang M., Morrell E.D., Meldrum K.K., Lillemoe K.D., et al. Stem cells improve right ventricular functional recovery after acute pressure overload and ischemia reperfusion injury. J Surg Res 141 (2007) 241-246
3. Borenstein N., Jian Z., Fromont G., Bruneval P., Hekmati M., Behr L., et al. Noncultured cell transplantation in an ovine model of right ventricular preparation. J Thorac Cardiovasc Surg 129 (2005) 1119-1127
4. Molina E.J., Palma J., Gupta D., Torres D., Gaughan J.P., Houser S., et al. Improvement in hemodynamic performance, exercise capacity, inflammatory profile and left ventricular reverse remodeling after intra-coronary delivery of mesenchymal stem cells (MSC) in an experimental model of pressure overload hypertrophy. J Thorac Cardiovasc Surg 135 (2008) 292-299
5. Schwarz E.J., Alexander G.M., Prockop D.J., and Azizi S.A. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson's disease. Hum Gene Ther 10 (1999) 2539-2549
6. Saito T., Kuang J.Q., Lin C.C., and Chiu R.C. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J Thorac Cardiovasc Surg 126 (2003) 114-123
7. Suzuki K., Murtuza B., Suzuki N., Smolenski R.T., and Yacoub M.H. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circulation 104 (2001) 213-217
8. Bristow M.R. Beta-adrenergic receptor blockade in chronic heart failure. Circulation 101 (2000) 558-569
9. Murry C.E., Field L.J., and Menasché P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 112 (2005) 3174-3183
10. Qian C., Tio R.A., Roks A.J., Boddeus K.M., Harmsen M.C., van Gilst W.H., et al. A promising technique for transplantation of bone marrow-derived endothelial progenitor cells into rat heart. Cardiovasc Pathol 16 (2007) 127-135
11. Sun M., Chen M., Dawood F., Zurawska U., Li J.Y., Parker T., et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115 (2007) 1398-1407
12. Kerkela R., and Force T. p38 mitogen-activated protein kinase: a future target for heart failure therapy?. J Am Coll Cardiol 48 (2006) 556-558
13. Spinale F.G., Coker M.L., Thomas C.V., Walker J.D., Mukherjee R., and Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res 82 (1998) 482-495
14. Webb C.S., Bonnema D.D., Ahmed S.H., Leonardi A.H., McClure C.D., Clark L.L., et al. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 114 (2006) 1020-1027
15. Thomas C.V., Coker M.L., Zellner J.L., Handy J.R., Crumbley III A.J., and Spinale F.G. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 97 (1998) 1708-1715
16. Polyakova V., Hein S., Kostin S., Ziegelhoeffer T., and Schaper J. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 44 (2004) 1609-1618